Metabolic Storage Diseases
Also known as: lysosomal storage diseases, metabolic storage diseases.
What are metabolic storage diseases?
Metabolic storage diseases are a fairly large group of rare genetic inherited disorders in which specific enzymes of a child's cell are insufficient. Enzymes help break down certain materials within the cell for proper cell function.
Without an appropriate enzyme balance, materials within the cell can accumulate and sometimes become toxic causing the cell to either not function properly or die.
Many vital organs such as the liver, the brain and more, can be affected.
What causes metabolic storage diseases?
Metabolic storage diseases are almost always inherited disorders (typically a single gene or enzyme) that are passed down from both parents to child.
What are the signs and symptoms of metabolic storage diseases?
Signs and symptoms vary widely based on which enzyme is deficient, and which cells/organ of the body are impacted. They are called storage diseases because the lack of enzymes to break down materials in the cells causes material to accumulate in the cells over time. As excess material accumulates in cells and the cells don't function properly, different parts of the body may be affected.
Symptoms can include:
- Enlarged organs (enlarged tongue, liver, spleen, etc.)
- Changes in the bones of the body (usually face and spine) due to enlarge organs
- Recurrent infections
- Impaired kidney function
- Impaired brain function,
- Eye abnormalities
- Heart abnormalities
- Abnormal coarse facial features
What are metabolic storage disease care options?
As there appears, at this time to be almost 50 storage diseases, treatments vary and will depend on the underlying disease and its signs and symptoms. Your specialist pediatrician will outline and explain all the options available.
Reviewed by: Parul B Jayakar, MD
This page was last updated on: 5/23/2018 2:58:19 PM
Nicklaus Children’s Hospital is excited to offer the Nutrition Symposium with an emphasis on the pediatric patient. Current research and technological advances in the care of pediatric conditions with nutrition implications will be presented by a multidisciplinary panel of speakers.
Learn more and register
From the Newsdesk
More than two dozen children attended the Bear Hug camp at Nicklaus Children's last week. This day camp is for siblings of pediatric cancer patients to encourage socialization among peers and help them gain insight on their siblings' care journey.
On this very same day nine years ago, Daniella Alvarez was diagnosed Teratoid Rhabdoid Tumor (ATRT), a rare and aggressive type of brain cancer. The news came on June 26, 2009, her second birthday. Daniella endured years of brain surgeries, aggressive chemotherapies, radiation, imaging scans, multiple visits to intensive care at Nicklaus Children’s Hospital. She is now cancer free thanks to a pediatric clinical trial made possible through research funding.
Meet our July Patient of the Month, Lacy. Lacy was only 2 years old when her parents noticed that something was wrong. They took her to various doctors to try to find what could be the cause, Lacy had an 8 cm. tumor in her brain, occupying most of the lower part of her head.